SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-003307
Filing Date
2018-11-08
Accepted
2018-11-08 16:11:42
Documents
50
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sonoma_10q-093018.htm 10-Q 334262
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER sonoma_10q-ex3101.htm EX-31.1 7865
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER sonoma_10q-ex3102.htm EX-31.2 7942
4 CERTIFICATION sonoma_10q-ex3201.htm EX-32.1 3696
  Complete submission text file 0001683168-18-003307.txt   2181771

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE snoa-20180930.xml EX-101.INS 391925
6 XBRL SCHEMA FILE snoa-20180930.xsd EX-101.SCH 22940
7 XBRL CALCULATION FILE snoa-20180930_cal.xml EX-101.CAL 42344
8 XBRL DEFINITION FILE snoa-20180930_def.xml EX-101.DEF 74934
9 XBRL LABEL FILE snoa-20180930_lab.xml EX-101.LAB 192390
10 XBRL PRESENTATION FILE snoa-20180930_pre.xml EX-101.PRE 158666
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 181169795
SIC: 2834 Pharmaceutical Preparations